Simulations Plus EBIT Margin 2010-2024 | SLP
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Simulations Plus (SLP) over the last 10 years. The current EBIT profit margin for Simulations Plus as of November 30, 2024 is .
| Simulations Plus EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2024-11-30 |
$0.08B |
$0.01B |
6.67% |
| 2024-08-31 |
$0.07B |
$0.01B |
8.45% |
| 2024-05-31 |
$0.07B |
$0.01B |
10.29% |
| 2024-02-29 |
$0.07B |
$0.01B |
13.85% |
| 2023-11-30 |
$0.06B |
$0.01B |
14.29% |
| 2023-08-31 |
$0.06B |
$0.01B |
15.00% |
| 2023-05-31 |
$0.06B |
$0.01B |
17.86% |
| 2023-02-28 |
$0.06B |
$0.01B |
20.00% |
| 2022-11-30 |
$0.05B |
$0.01B |
22.22% |
| 2022-08-31 |
$0.05B |
$0.02B |
27.78% |
| 2022-05-31 |
$0.05B |
$0.01B |
26.92% |
| 2022-02-28 |
$0.05B |
$0.01B |
28.00% |
| 2021-11-30 |
$0.05B |
$0.01B |
25.00% |
| 2021-08-31 |
$0.05B |
$0.01B |
23.40% |
| 2021-05-31 |
$0.05B |
$0.01B |
27.66% |
| 2021-02-28 |
$0.05B |
$0.01B |
26.09% |
| 2020-11-30 |
$0.04B |
$0.01B |
27.91% |
| 2020-08-31 |
$0.04B |
$0.01B |
29.27% |
| 2020-05-31 |
$0.04B |
$0.01B |
30.77% |
| 2020-02-29 |
$0.04B |
$0.01B |
32.43% |
| 2019-11-30 |
$0.04B |
$0.01B |
34.29% |
| 2019-08-31 |
$0.03B |
$0.01B |
32.35% |
| 2019-05-31 |
$0.03B |
$0.01B |
33.33% |
| 2019-02-28 |
$0.03B |
$0.01B |
31.25% |
| 2018-11-30 |
$0.03B |
$0.01B |
29.03% |
| 2018-08-31 |
$0.03B |
$0.01B |
33.33% |
| 2018-05-31 |
$0.03B |
$0.01B |
31.03% |
| 2018-02-28 |
$0.03B |
$0.01B |
33.33% |
| 2017-11-30 |
$0.03B |
$0.01B |
34.62% |
| 2017-08-31 |
$0.02B |
$0.01B |
33.33% |
| 2017-05-31 |
$0.02B |
$0.01B |
36.36% |
| 2017-02-28 |
$0.02B |
$0.01B |
38.10% |
| 2016-11-30 |
$0.02B |
$0.01B |
40.00% |
| 2016-08-31 |
$0.02B |
$0.01B |
40.00% |
| 2016-05-31 |
$0.02B |
$0.01B |
40.00% |
| 2016-02-29 |
$0.02B |
$0.01B |
40.00% |
| 2015-11-30 |
$0.02B |
$0.01B |
35.00% |
| 2015-08-31 |
$0.02B |
$0.01B |
31.58% |
| 2015-05-31 |
$0.02B |
$0.01B |
29.41% |
| 2015-02-28 |
$0.02B |
$0.00B |
26.67% |
| 2014-11-30 |
$0.01B |
$0.00B |
30.77% |
| 2014-08-31 |
$0.01B |
$0.00B |
33.33% |
| 2014-05-31 |
$0.01B |
$0.00B |
33.33% |
| 2014-02-28 |
$0.01B |
$0.00B |
36.36% |
| 2013-11-30 |
$0.01B |
$0.01B |
45.45% |
| 2013-08-31 |
$0.01B |
$0.01B |
50.00% |
| 2013-05-31 |
$0.01B |
$0.01B |
50.00% |
| 2013-02-28 |
$0.01B |
$0.00B |
40.00% |
| 2012-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2012-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2012-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2012-02-29 |
$0.01B |
$0.00B |
30.00% |
| 2011-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2011-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2011-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2011-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2010-11-30 |
$0.01B |
$0.00B |
30.00% |
| 2010-08-31 |
$0.01B |
$0.00B |
30.00% |
| 2010-05-31 |
$0.01B |
$0.00B |
30.00% |
| 2010-02-28 |
$0.01B |
$0.00B |
30.00% |
| 2009-11-30 |
$0.01B |
$0.00B |
33.33% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.624B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
